{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T01:42:59Z","timestamp":1779327779277,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Importance<\/jats:title>\n                <jats:p>COVID-19 has adversely affected global healthcare infrastructure since 2019. Currently, there are no large-scale published reports on the efficacy of combination therapy of dexamethasone, remdesivir, and tocilizumab on COVID-19 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Is the combination therapy of dexamethasone, remdesivir, and tocilizumab superior to other treatments on hospitalized COVID-19 patients?<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Design<\/jats:title>\n                <jats:p>This is a retrospective, comparative effectiveness study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Setting<\/jats:title>\n                <jats:p>Single-center study<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Participants\/interventions<\/jats:title>\n                <jats:p>We analyzed different inpatient COVID-19 treatment options available in the United States and their impact on hospital length of stay (LOS) and mortality. Hospitalized COVID-19 were categorized as \u201cmild,\u201d \u201cmoderate\u201d and \u201csevere'' based on the highest level of oxygen required; room air, nasal cannula, or high flow\/PAP\/intubation, respectively. Patients were treated in accordance with the availability of medications and the latest treatment guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main outcomes<\/jats:title>\n                <jats:p>The endpoints of the study are hospital discharges and death during hospitalization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>1233 COVID-19 patients were admitted from 2020 to 2021. No treatment combinations showed a statistically significant decrease in hospital LOS in mild COVID-19 patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.186). In moderate patients, the combination of remdesivir and dexamethasone slightly decreased LOS by 1\u00a0day (<jats:italic>p<\/jats:italic>\u2009=\u20090.007). In severe patients, the three-drug combination of remdesivir, dexamethasone, and tocilizumab decreased LOS by 8\u00a0days (<jats:italic>p<\/jats:italic>\u2009=\u20090.0034) when compared to nonviable treatments, such as hydroxychloroquine and convalescent plasma transfusion. However, it did not show any statistically significant benefit when compared to two-drug regimens (dexamethasone plus remdesivir) in severe COVID-19 (<jats:italic>p<\/jats:italic>\u2009=\u20090.116). No treatment arm appeared to show a statistically significant decrease in mortality for severe COVID-19 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that three-drug combination may decrease LOS in severe COVID-19 patients when compared to two-drug therapy. However, the trend was not supported by statistical analysis. Remdesivir may not be clinically beneficial for mild hospitalized COVID-19 patients; considering its cost, one could reserve it for moderate and severe patients. Triple drug therapies, while potentially reducing LOS for severe patients, do not affect overall mortality. Additional patient data may increase statistical power and solidify these findings.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01201-8","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T08:01:38Z","timestamp":1688371298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Different COVID-19 treatments\u2019 impact on hospital length of stay"],"prefix":"10.1186","volume":"28","author":[{"given":"Satori","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahaar Kaur","family":"Muhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mason","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"publisher","DOI":"10.1177\/08971900221097248","author":"BK Muhar","year":"2022","unstructured":"Muhar BK, Nehira J, Malhotra A, Kotchoni SO. The race for COVID-19 vaccines: the various types and their strengths and weaknesses. J Pharm Pract. 2022. https:\/\/doi.org\/10.1177\/08971900221097248.","journal-title":"J Pharm Pract"},{"key":"1201_CR2","unstructured":"World Health Organization, WHO coronavirus (COVID-19) dashboard., https:\/\/covid19.who.int Accessed from 15 Jan 2023."},{"key":"1201_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tacc.2020.09.005","volume":"36","author":"C Deana","year":"2021","unstructured":"Deana C, Verriello L, Pauletto G, Corradi F, Forfori F, Cammarota G, Bignami E, Vetrugno L, Bove T. Insights into neurological dysfunction of critically ill COVID-19 patients. Trends Anaesthesia Critical Care. 2021;36:30\u20138. https:\/\/doi.org\/10.1016\/j.tacc.2020.09.005.","journal-title":"Trends Anaesthesia Critical Care"},{"key":"1201_CR4","doi-asserted-by":"publisher","DOI":"10.5291\/jmrs224074","author":"S Iwamoto","year":"2022","unstructured":"Iwamoto S, Johnstone M, Chiu M, Chu H. Acute ischemic stroke in a young woman with an otherwise asymptomatic SARS-CoV-2 infection. J Med Res Surg. 2022. https:\/\/doi.org\/10.5291\/jmrs224074.","journal-title":"J Med Res Surg"},{"key":"1201_CR5","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.3906\/sag-2106-250","volume":"51","author":"S \u015eim\u015fek-Yavuz","year":"2021","unstructured":"\u015eim\u015fek-Yavuz S, Komsuo\u011flu \u00c7elikyurt FI. An update of anti-viral treatment of COVID-19. Turk J Med Sci. 2021;51:3372\u201390.","journal-title":"Turk J Med Sci"},{"issue":"1","key":"1201_CR6","first-page":"402","volume":"8","author":"S Iwamoto","year":"2022","unstructured":"Iwamoto S, Muhar BK, Sidhu A, Chu H, Chiu M, Spantzel H, Chu H, Zhou N, Spantzel A, Zhang E, Chu G. Predicting oxygen utilization & nurse staffing needs for SARS-CoV-2. J Bioinform Neurosci. 2022;8(1):402\u20139.","journal-title":"J Bioinform Neurosci"},{"key":"1201_CR7","unstructured":"U.S. Department of Health and Human Services, Hospitalized adults: Therapeutic management. National Institutes of Health., https:\/\/www.covid19treatmentguidelines.nih.gov\/tables\/therapeutic-management-of-hospitalized-adults\/ Accessed from 15 Jan 2023."},{"issue":"8","key":"1201_CR8","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704.","journal-title":"N Engl J Med"},{"issue":"9","key":"1201_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S2213-2600(22)00088-1","volume":"10","author":"CR Wolfe","year":"2022","unstructured":"Wolfe CR, Tomashek KM, Patterson TF, Gomez CA, Marconi VC, Jain MK, Yang OO, Paules CI, Palacios GMR, Grossberg R, Harkins MS, Mularski RA, Erdmann N, Sandkovsky U, Almasri E, Pineda JR, Dretler AW, de Castilla DL, Branche AR, Park PK, Mehta AK, Short WR, McLellan SLF, Kline S, Iovine NM, El Sahly HM, Doernberg SB, Oh MD, Huprikar N, Hohmann E, Kelley CF, Holodniy M, Kim ES, Sweeney DA, Finberg RW, Grimes KA, Maves RC, Ko ER, Engemann JJ, Taylor BS, Ponce PO, Larson L, Melendez DP, Seibert AM, Rouphael NG, Strebe J, Clark JL, Julian KG, de Leon AP, Cardoso A, de Bono S, Atmar RL, Ganesan A, Ferreira JL, Green M, Makowski M, Bonnett T, Beresnev T, Ghazaryan V, Dempsey W, Nayak SU, Dodd LE, Beigel JH, Kalil AC. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial. Lancet Respir Med. 2022;10(9):888\u201399.","journal-title":"Lancet Respir Med"},{"issue":"13","key":"1201_CR10","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"BM Tomazini","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, Avezum A, Lopes RD, Bueno FR, Silva M, Baldassare FP, Costa ELV, Moura RAB, Honorato MO, Costa AN, Damiani LP, Lisboa T, Kawano-Dourado L, Zampieri FG, Olivato GB, Righy C, Amendola CP, Roepke RML, Freitas DHM, Forte DN, Freitas FGR, Fernandes CCF, Melro LMG, Junior GFS, Morais DC, Zung S, Machado FR, Azevedo LCP. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324(13):1307\u201316.","journal-title":"JAMA"},{"key":"1201_CR11","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2020-4-14","author":"J Pardo","year":"2020","unstructured":"Pardo J, Shukla AM, Chamarthi G, Gupte A. The journey of remdesivir: from Ebola to COVID-19. Drugs Context. 2020. https:\/\/doi.org\/10.7573\/dic.2020-4-14.","journal-title":"Drugs Context"},{"key":"1201_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2021.100794","volume":"59","author":"S Dro\u017cd\u017cal","year":"2021","unstructured":"Dro\u017cd\u017cal S, Rosik J, Lechowicz K, Machaj F, Szostak B, Przybyci\u0144ski J, Lorzadeh S, Kotfis K, Ghavami S, \u0141os MJ. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment. Drug Resist Updat. 2021;59: 100794.","journal-title":"Drug Resist Updat"},{"issue":"10285","key":"1201_CR13","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","unstructured":"RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2021;397(10285):1637\u201345.","journal-title":"Lancet"},{"issue":"2","key":"1201_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262564","volume":"17","author":"SB Gressens","year":"2022","unstructured":"Gressens SB, Esnault V, De Castro N, Sellier P, Sene D, Chantelot L, Hervier B, Delaugerre C, Chevret S, Molina JM. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: a retrospective multicenter study. PLoS ONE. 2022;17(2): e0262564.","journal-title":"PLoS ONE"},{"key":"1201_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejim.2020.08.019","volume":"82","author":"COVID-19 RISK and Treatments (CORIST) Collaboration","year":"2020","unstructured":"COVID-19 RISK and Treatments (CORIST) Collaboration. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: findings from the observational multicentre Italian CORIST study. Eur J Intern Med. 2020;82:38\u201347. https:\/\/doi.org\/10.1016\/j.ejim.2020.08.019.","journal-title":"Eur J Intern Med"},{"key":"1201_CR16","doi-asserted-by":"publisher","first-page":"639970","DOI":"10.3389\/fmed.2021.639970","volume":"8","author":"A Di Castelnuovo","year":"2021","unstructured":"Di Castelnuovo A, Costanzo S, Antinori A, Berselli N, Blandi L, Bonaccio M, Bruno R, Cauda R, Gialluisi A, Guaraldi G, Menicanti L, Mennuni M, My I, Parruti A, Patti G, Perlini S, Santilli F, Signorelli C, Stefanini GG, Vergori A, Ageno W, Aiello L, Agostoni P, Al Moghazi S, Arboretti R, Aucella F, Barbieri G, Barchitta M, Bartoloni A, Bologna C, Bonfanti P, Caiano L, Carrozzi L, Cascio A, Castiglione G, Chiarito M, Ciccullo A, Cingolani A, Cipollone F, Colomba C, Colombo C, Crosta F, Dalena G, Dal Pra C, Danzi GB, D\u2019Ardes D, de Gaetano DK, Di Gennaro F, Di Tano G, D\u2019Offizi G, Filippini T, Maria Fusco F, Gaudiosi C, Gentile I, Gini G, Grandone E, Guarnieri G, Lamanna GLF, Larizza G, Leone A, Lio V, Losito AR, Maccagni G, Maitan S, Mancarella S, Manuele R, Mapelli M, Maragna R, Marra L, Maresca G, Marotta C, Mastroianni F, Mazzitelli M, Mengozzi A, Menichetti F, Milic J, Minutolo F, Molena B, Mussinelli R, Mussini C, Musso M, Odone A, Olivieri M, Pasi E, Perroni A, Petri F, Pinchera B, Pivato CA, Poletti V, Ravaglia C, Rossato M, Rossi M, Sabena A, Salinaro F, Sangiovanni V, Sanrocco C, Scorzolini L, Sgariglia R, Simeone PG, Spinicci M, Trecarichi EM, Veronesi G, Vettor R, Vianello A, Vinceti M, Visconti E, Vocciante L, De Caterina R, Iacoviello L, COVID-19 RISK and Treatments (CORIST) Collaboration. Lopinavir\/ritonavir and darunavir\/cobicistat in hospitalized COVID-19 patients: findings from the multicenter Italian CORIST Study. Front Med. 2021;8:639970. https:\/\/doi.org\/10.3389\/fmed.2021.639970.","journal-title":"Front Med"},{"issue":"4","key":"1201_CR17","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3390\/ijerph19042224","volume":"19","author":"AJ Zeleke","year":"2022","unstructured":"Zeleke AJ, Moscato S, Miglio R, Chiari L. Length of stay analysis of COVID-19 hospitalizations using a count regression model and quantile regression: a Study in Bologna, Italy. Int J Environ Res Public Health. 2022;19(4):2224.","journal-title":"Int J Environ Res Public Health"},{"key":"1201_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jss.2020.11.062","volume":"260","author":"B Sen-Crowe","year":"2021","unstructured":"Sen-Crowe B, Sutherland M, McKenney M, Elkbuli A. A closer look into global hospital beds capacity and resource shortages during the COVID-19 Pandemic. J Surg Res. 2021;260:56\u201363.","journal-title":"J Surg Res"},{"key":"1201_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182211825","author":"J Wang","year":"2021","unstructured":"Wang J, Kim S. The paradox of conspiracy theory: the positive impact of beliefs in conspiracy theories on preventive actions and vaccination intentions during the COVID-19 Pandemic. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph182211825.","journal-title":"Int J Environ Res Public Health"},{"key":"1201_CR20","doi-asserted-by":"publisher","first-page":"05031","DOI":"10.7189\/jogh.12.05031","volume":"12","author":"L Polivka","year":"2022","unstructured":"Polivka L, Gajdacsi J, Fazekas L, Sebok S, Barczi E, Hidvegi E, Sutto Z, Dinya E, Maurovich-Horvat P, Szabo AJ, Merkely B, M\u00fcller V. Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment. J Glob Health. 2022;12:05031.","journal-title":"J Glob Health"},{"issue":"1","key":"1201_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jhep.2020.09.031","volume":"74","author":"T Asselah","year":"2021","unstructured":"Asselah T, Durantel D, Pasmant E, Lau G, Schinazi RF. COVID-19: discovery, diagnostics and drug development. J Hepatol. 2021;74(1):168\u201384.","journal-title":"J Hepatol"},{"issue":"4","key":"1201_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.resinv.2022.04.001","volume":"60","author":"T Ichiyama","year":"2022","unstructured":"Ichiyama T, Komatsu M, Wada Y, Hanaoka M. Report of a combination of remdesivir, intravenous methylprednisolone pulse, and tocilizumab for severe coronavirus disease: 20-case series at a single institution. Respir Investig. 2022;60(4):604\u20136.","journal-title":"Respir Investig"},{"key":"1201_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015209","author":"A Kramer","year":"2022","unstructured":"Kramer A, Prinz C, Fichtner F, Fischer AL, Thieme V, Grundeis F, Spagl M, Seeber C, Piechotta V, Metzendorf MI, Golinski M, Moerer O, Stephani C, Mikolajewska A, Kluge S, Stegemann M, Laudi S, Skoetz N. Janus kinase inhibitors for the treatment of COVID-19. Cochrane Database Syst Rev. 2022. https:\/\/doi.org\/10.1002\/14651858.CD015209.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1201_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10238-020-00671-y","volume":"21","author":"M Gavriatopoulou","year":"2021","unstructured":"Gavriatopoulou M, Ntanasis-Stathopoulos I, Korompoki E, Fotiou D, Migkou M, Tzanninis IG, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA. Emerging treatment strategies for COVID-19 infection. Clin Exp Med. 2021;21(2):167\u201379.","journal-title":"Clin Exp Med"},{"key":"1201_CR25","first-page":"e01083","volume":"15","author":"AF Fagbamigbe","year":"2022","unstructured":"Fagbamigbe AF, Tolba MF, Amankwaa EF, Mante PK, Sylverken AA, Zahouli JZB, Goonoo N, Mosi L, Oyebola K, Matoke-Muhia D, de Souza DK, Badu K, Dukhi N. Implications of WHO COVID-19 interim guideline 2020 5 on the comprehensive care for infected persons in Africa Before, during and after clinical management of cases. Sci Afr. 2022;15:e01083.","journal-title":"Sci Afr"},{"issue":"5","key":"1201_CR26","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jval.2022.02.002","volume":"25","author":"J Chhatwal","year":"2022","unstructured":"Chhatwal J, Basu A. Cost-effectiveness of remdesivir for COVID-19 treatment: what are we missing? Value Health. 2022;25(5):697\u20138.","journal-title":"Value Health"},{"issue":"3","key":"1201_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/BOR.0000000000000786","volume":"33","author":"KM D'Silva","year":"2021","unstructured":"D\u2019Silva KM, Wallace ZS. COVID-19 and rheumatoid arthritis. Curr Opin Rheumatol. 2021;33(3):255\u201361.","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"1201_CR28","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMc2022236","volume":"383","author":"JH McMahon","year":"2020","unstructured":"McMahon JH, Udy A, Peleg AY. Remdesivir for the treatment of Covid-19\u2014preliminary report. N Engl J Med. 2020;383(10):992\u20133.","journal-title":"N Engl J Med"},{"key":"1201_CR29","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2020.1508","author":"I Ambrosino","year":"2020","unstructured":"Ambrosino I, Barbagelata E, Corbi G, Ciarambino T, Politi C, Moretti AM. Gender differences in treatment of Coronavirus Disease-2019. Monaldi Arch Chest Dis. 2020. https:\/\/doi.org\/10.4081\/monaldi.2020.1508.","journal-title":"Monaldi Arch Chest Dis"},{"issue":"7344","key":"1201_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/bmj.324.7344.1010","volume":"324","author":"V Grech","year":"2002","unstructured":"Grech V, Savona-Ventura C, Vassallo-Agius P. Research pointers: unexplained differences in sex ratios at birth in Europe and North America. BMJ. 2002;324(7344):1010\u20131.","journal-title":"BMJ"},{"key":"1201_CR31","unstructured":"Centers for Disease Control and Prevention, Covid-19 hospitalizations. Centers for Disease Control and Prevention., https:\/\/gis.cdc.gov\/grasp\/COVIDNet\/COVID19_5.html (Accessed from 15 Jan 2023)."},{"key":"1201_CR32","first-page":"204993612210956","volume":"9","author":"H Senderovich","year":"2022","unstructured":"Senderovich H, Vinoraj D, Stever M, Waicus S. Efficacy of COVID-19 treatments among geriatric patients: a systematic review. Ther Adv Infect Dis. 2022;9:20499361221095664.","journal-title":"Ther Adv Infect Dis"},{"key":"1201_CR33","doi-asserted-by":"publisher","first-page":"175346662096301","DOI":"10.1177\/1753466620963016","volume":"14","author":"G Procopio","year":"2020","unstructured":"Procopio G, Cancelliere A, Trecarichi EM, Mazzitelli M, Arrighi E, Perri G, Serapide F, Pelaia C, Lio E, Busceti MT, Pelle MC, Ricchio M, Scaglione V, Davoli C, Fusco P, La Gamba V, Torti C, Pelaia G. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. Ther Adv Respir Dis. 2020;14:1753466620963016. https:\/\/doi.org\/10.1177\/1753466620963016.","journal-title":"Ther Adv Respir Dis"},{"key":"1201_CR34","doi-asserted-by":"publisher","first-page":"135564","DOI":"10.1016\/j.neulet.2020.135564","volume":"743","author":"A Vogrig","year":"2021","unstructured":"Vogrig A, Gigli GL, Bn\u00e0 C, et al. Stroke in patients with COVID19: clinical and neuroimaging characteristics. Neurosci Lett. 2021;743:135564.","journal-title":"Neurosci Lett."},{"issue":"2","key":"1201_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.52916\/jmrs224074","volume":"3","author":"S Iwamoto","year":"2022","unstructured":"Iwamoto S, Johnstone M, Chiu M, et al. Acute ischemic stroke in a young woman with an otherwise asymptomatic SARS-CoV-2 infection. J Med Res Surg. 2022;3(2):38\u201340. https:\/\/doi.org\/10.52916\/jmrs224074.","journal-title":"J Med Res Surg"},{"issue":"8","key":"1201_CR36","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1055\/a-1347-6070","volume":"121","author":"A Di Castelnuovo","year":"2021","unstructured":"Di Castelnuovo A, Costanzo S, Antinori A, Berselli N, Blandi L, Bonaccio M, Cauda R, Guaraldi G, Menicanti L, Mennuni M, Parruti G, Patti G, Santilli F, Signorelli C, Vergori A, Abete P, Ageno W, Agodi A, Agostoni P, Aiello L, Al Moghazi S, Arboretti R, Astuto M, Aucella F, Barbieri G, Bartoloni A, Bonfanti P, Cacciatore F, Caiano L, Carrozzi L, Cascio A, Ciccullo A, Cingolani A, Cipollone F, Colomba C, Colombo C, Crosta F, Danzi GB, D\u2019Ardes D, de Gaetano DK, Di Gennaro F, Di Tano G, D\u2019Offizi G, Fantoni M, Fusco FM, Gentile I, Gianfagna F, Grandone E, Graziani E, Grisafi L, Guarnieri G, Larizza G, Leone A, Maccagni G, Madaro F, Maitan S, Mancarella S, Mapelli M, Maragna R, Marcucci R, Maresca G, Marongiu S, Marotta C, Marra L, Mastroianni F, Mazzitelli M, Mengozzi A, Menichetti F, Meschiari M, Milic J, Minutolo F, Molena B, Montineri A, Mussini C, Musso M, Niola D, Odone A, Olivieri M, Palimodde A, Parisi R, Pasi E, Pesavento R, Petri F, Pinchera B, Poletti V, Ravaglia C, Rognoni A, Rossato M, Rossi M, Sangiovanni V, Sanrocco C, Scorzolini L, Sgariglia R, Simeone PG, Taddei E, Torti C, Vettor R, Vianello A, Vinceti M, Virano A, Vocciante L, De Caterina R, Iacoviello L. Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicenter Italian CORIST Study. Thromb Haemost. 2021;121(8):1054\u201365. https:\/\/doi.org\/10.1055\/a-1347-6070.","journal-title":"Thromb Haemost"},{"issue":"24","key":"1201_CR37","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1056\/NEJMoa2028836","volume":"383","author":"JH Stone","year":"2020","unstructured":"Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes AS, Horick NK, Healy BC, Shah R, Bensaci AM, Woolley AE, Nikiforow S, Lin N, Sagar M, Schrager H, Huckins DS, Axelrod M, Pincus MD, Fleisher J, Sacks CA, Dougan M, North CM, Halvorsen YD, Thurber TK, Dagher Z, Scherer A, Wallwork RS, Kim AY, Schoenfeld S, Sen P, Neilan TG, Perugino CA, Unizony SH, Collier DS, Matza MA, Yinh JM, Bowman KA, Meyerowitz E, Zafar A, Drobni ZD, Bolster MB, Kohler M, D\u2019Silva KM, Dau J, Lockwood MM, Cubbison C, Weber BN, Mansour MK. Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med. 2020;383(24):2333\u201344.","journal-title":"N Engl J Med"},{"issue":"13","key":"1201_CR38","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s40265-020-01378-w","volume":"80","author":"YN Lamb","year":"2020","unstructured":"Lamb YN. Remdesivir: first approval. Drugs. 2020;80(13):1355\u201363.","journal-title":"Drugs"},{"key":"1201_CR39","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https:\/\/www.covid19treatmentguidelines.nih.gov\/. Accessed from 17 Jun 2023."},{"issue":"2","key":"1201_CR40","doi-asserted-by":"publisher","first-page":"e2021097","DOI":"10.2375\/abm.v92i2.11159","volume":"92","author":"C Deana","year":"2021","unstructured":"Deana C, Rovida S, Orso D, Bove T, Bassi F, De Monte A, Vetrugno L. Learning from the Italian experience during COVID-19 pandemic waves: be prepared and mind some crucial aspects. Acta Biomed. 2021;92(2):e2021097. https:\/\/doi.org\/10.2375\/abm.v92i2.11159.","journal-title":"Acta Biomed"},{"key":"1201_CR41","doi-asserted-by":"publisher","first-page":"e0277413","DOI":"10.1371\/journal.pone.0277413","volume":"1711","author":"S Zamani","year":"2022","unstructured":"Zamani S, Alizadeh M, Shahrestanaki E, Mohammadpoor Nami S, Qorbani M, Aalikhani M, Hassani Gelsefid S, Mohammadian Khonsari N. Prognostic comparison of COVID-19 outpatients and inpatients treated with Remdesivr: a retrospective cohort study. PLoS ONE. 2022;1711:e0277413.","journal-title":"PLoS ONE"},{"key":"1201_CR42","unstructured":"Centers for Disease Control and Prevention, SARS-COV-2 variant classifications and definitions. Centers for Disease Control and Prevention., https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/variant-classifications.html#anchor_1632154493691 Accessed from 15 Jan 2023."},{"key":"1201_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111926","author":"VP Chavda","year":"2022","unstructured":"Chavda VP, Bezbaruah R, Deka K, Nongrang L, Kalita T. The Delta and Omicron variants of SARS-CoV-2: what we know so far. Vaccines. 2022. https:\/\/doi.org\/10.3390\/vaccines10111926.","journal-title":"Vaccines"},{"issue":"1","key":"1201_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.36502\/2022\/hcr.6206","volume":"1","author":"BK Muhar","year":"2022","unstructured":"Muhar BK, Chu H, Zhou N. Retrospective cross-sectional analysis of COVID-19 patients in a local hospital during delta surge. J Health Care Res. 2022;1(1):11\u20135.","journal-title":"J Health Care Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01201-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01201-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01201-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T08:07:59Z","timestamp":1688371679000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01201-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01201-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study, IRB# 00001045, has been reviewed and approved by the Kaiser Permanente Northern California IRB (KPNC) Institutional Review Board (IRB) on December 8, 2021. The IRB, which also serves as the Privacy Board, waived the requirement to obtain Privacy Rule Authorization for the use and disclosure of protected health information (PHI) as allowed under [45 CFR 164.512(i)(1)(i)].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors listed certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, participation in speakers' bureaus, membership, employment, consultancies, stock ownership, or other equity interest, expert testimony, or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}